Home > Healthcare > Medical Devices > Diagnostic Devices > Imaging Agents Market

Imaging Agents Market Share

Report ID: GMI5267
Published Date: May 2022
Report Format: PDF

Download Free Sample

Imaging Agents Market Share

Some of the key market players operating in the imaging agents industry include

GE Healthcare
Eli Lily
Bayer Healthcare Pharmaceuticals
Alliance Medical
Bracco Diagnostics, Inc.
Aytu BioScience, Inc.
Curium
Guerbet Group
Lantheus Medical Imaging, Inc.
Trivitron Healthcare
Beijing Beilu Pharmaceutical Co Ltd.

These market participants are formulating various growth strategies with continued innovations and technology improvements to sustain market competition in the imaging agents market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Imaging agents market is slated to surpass USD 14.2 billion by 2030 and is anticipated to grow at a CAGR of 5% between 2022 to 2030 considering the rising number of cancer cases at the global level.

The market revenue from oncology application accounted for nearly USD 2.3 billion in 2021 and is estimated to depict substantial growth through 2030 driven by the escalating demand for colorectal cancer screening.

North America imaging agents market is slated to expand at a CAGR of 4.9% from 2022 to 2030 impelled by the increasing R&D investments & healthcare infrastructure.

Prominent players in the imaging agents market include Lantheus Medical Imaging Inc., Bayer Healthcare Pharmaceuticals, Guerbet Group, Eli Lily, Bracco Diagnostics, Inc., GE Healthcare, Alliance Medical, Beijing Beilu Pharmaceutical Co. Ltd., Alliance Medical, Aytu Bioscience, Inc., and others.